Media

News

Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

October 16, 2019

Updated analysis for larotrectinib confirms high response rate and durable responses over three years in children and adults with TRK fusion cancer

79% overall response rate (ORR) in 153 evaluable adult and pediatric patients at time of new data cut off (February 19, 2019); results consistent with previous publications / Similar ORR of 75% in patients with brain metastases1, adding to the previously reported evidence for larotrectinib’s activity in central nervous system (CNS) / Median progression free survival (mPFS) of 28.3 months and median overall survival (mOS) of more than three years (44.4 months) was achieved; median duration of response (mDOR) of nearly three years1 / Largest dataset with longest follow-up of any TRK inhibitor illustrates favourable safety profile across ages and tumour types Read more
October 02, 2019

Bayer Fund shares over $100,000 in funding with students through its Opportunity Scholarship Program

67 Canadian students pursuing post-secondary education in agriculture and food-related disciplines Read more
September 03, 2019

Bayer completes sale of iconic Coppertone™ brand to Beiersdorf

Divestiture enables Bayer to focus on core OTC business Read more
July 30, 2019

Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion

Read more
July 22, 2019

Yellow Wood Partners to acquire iconic Dr. Scholl’s™ brand from Bayer

Yellow Wood Partners and Bayer announced today that Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer for a purchase price of 585 million U.S. dollars. Read more
May 14, 2019

Beiersdorf to acquire iconic Coppertone™ brand from Bayer

Divestiture enables Bayer to focus on core OTC business Read more
April 04, 2019

Delaro fungicide now registered for cereals

The new registration delivers exceptional and long-lasting control of leaf diseases in cereals Read more
March 25, 2019

Bayer Fund to provide nearly $100,000 in scholarships to eligible Canadian high school students in 2019

Sixty-five of the best and brightest grade 12 graduating students from across the country will receive a $1,500 scholarship to pursue post-secondary education in an agriculture or food-related discipline Read more
March 11, 2019

New Single-dose Treatment for Canine Otitis Externa Launches in Canada

Claro® provides veterinarians with an effective first-line therapy that eliminates the need for in-home application by pet owners Read more
March 06, 2019

Bayer Inc. investing $500,000 in STEM education for Canadian youth through Let’s Talk Science

Read more